NEPTUNE, N.J., Dec. 13 /PRNewswire/ -- InfaCare Pharmaceutical Corporation announced today that John R. Post has been appointed President and Chief Executive Officer of the Company. InfaCare is a specialty pharmaceutical company focused on developing innovative therapies for neonates and older children. The company is based in Neptune, NJ.
"The Board of Directors is extremely pleased with this appointment," said Dr. Vukovich, InfaCare's founder and Chairman. "John's general management, marketing and sales background provides an ideal blend of operational experience which will allow him to provide the strategic leadership InfaCare now requires. Over his 29-year career in the industry, John has acquired extensive experience in the area of new products, from providing commercial perspective in early drug development to preparing and executing new product launches. We are delighted at John's decision to join InfaCare and look forward to his leadership at an important time in the company's development."
InfaCare Pharmaceutical Corporation is a privately held pharmaceutical company founded in 2001 by Dr. Robert A. Vukovich. The company is currently developing Stanate(R) for the treatment of hyperbilirubinemia (elevated bilirubin levels leading to jaundice and possible neurological damage) in neonates. Commenting on his new assignment, Mr. Post said, "I look forward to building and leading the organization as it pursues the regulatory approval of Stanate(R)."
John's entire career has been spent in the pharmaceutical industry where he successfully served the interests of Pfizer Inc. and Boehringer Ingelheim Pharmaceuticals Inc. Prior to his appointment as Chief Operating Officer of InfaCare in June 2004, John served the interests of Pfizer as Area President, Europe/Africa/Middle East/Canada for their Animal Health Division. Other positions held at Pfizer include Vice President, Marketing; Vice President, US Livestock Division; General Manager, Canadian Operations, as well as a variety of sales and marketing positions within the human pharmaceutical division. While at Boehringer Ingelheim, John served in a variety of senior marketing positions, ultimately heading up the US human health marketing operation. Mr. Post received his BA in Zoology from the University of Santa Barbara.
Contact: Nancy Bracken
Tel: (732) 938-5885
Fax: (732) 751-9056
InfaCare Pharmaceutical Corporation
CONTACT: Nancy Bracken of InfaCare Pharmaceutical Corporation,+1-732-938-5885, or fax, +1-732-751-9056